Listerine, a generically-developed drug used to treat asthma, is widely used to relieve symptoms of asthma and other respiratory conditions.
The company is now facing an internal investigation by regulators that is expected to result in a recall of approximately 100 million oral health products, according to the Wall Street Journal.
Listerines use of hydrogen sulfide to kill bacteria in the oral cavity is one of the reasons listerines are now being blamed for the rise of cavities.
The WSJ notes that Listerino, a company that makes oral health capsules, has not responded to questions about why the products are in the market and whether the products were recalled.
The investigation is ongoing, but one person familiar with the matter told the Journal that the company was working to resolve the issue with regulators.
Listers manufacturer, Listeria Group, has also responded to a request for comment, saying in a statement that it is working with the FDA to address the issue and that it was cooperating with the investigation.
The Journal reports that the investigation is being conducted by the FDA’s Center for Food Safety and Applied Nutrition.
The Center for food safety and applied nutrition is an independent, independent watchdog agency that monitors and reports on food safety issues in the United States.
The FDA did not respond to a message seeking comment from CNBC.
The Listerina outbreak is the latest in a string of recalls of oral health and other products linked to the use of Listerin.
The Centers for Disease Control and Prevention recently released a list of Listers products that are believed to be contaminated with Listerion, a drug that causes oral infections.